Boots WebMD Partners in Health
Return To Boots

Pregnancy health centre

Postnatal depression references

BMJ Group Medical Reference

References

  1. Zonana J, Gorman JM. The neurobiology of postpartum depression. CNS Spectrums. 2005; 10: 792-799, 805.
  2. Clay EC, Seehusen DA. A review of postpartum depression for the primary care physician. Southern Medical Journal. 2004; 97: 157-161.
  3. Wisner KL, Parry BL, Piontek CM. Clinical Practice. Postpartum depression. New England Journal of Medicine. 2002; 347: 194-199.
  4. Evans J, Heron J, Francomb H, et al. Cohort study of depressed mood during pregnancy and after childbirth. BMJ. 2001; 323: 257-260.
  5. Dennis CL, Allen K. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  6. Chaudron LH. Postpartum depression: what pediatricians need to know. Pediatric Review. 2003; 24: 154-161.
  7. Cooper PJ, Murray L. Fortnightly review: postnatal depression. BMJ. 1998; 316: 1884-1886.
  8. Bloch M, Rotenberg N, Koren D. Risk factors associated with the development of postpartum mood disorders. Journal of Affective Disorders. 2005; 88: 9-18.
  9. Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Comprehensive Psychiatry. 2003; 44: 234-246.
  10. Bloch M, Schmidt PJ, Danaceau M. Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry. 2000; 157: 924-930.
  11. Clay EC, Seehusen DA. A review of postpartum depression for the primary care physician. Southern Medical Journal. 2004; 97: 157-161.
  12. Henshaw C. Mood disturbance in the early puerperium: a review. Archive of Women's Mental Health. 2003; 6: 33-42.
  13. O'Hara MW, Swain AM. Rates and risks of postpartum depression: a meta-analysis. International Review of Psychiatry. 1996; 8: 37-54.
  14. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychosis. British Journal of Psychiatry. 1987; 150: 662-673.
  15. Clay EC, Seehusen DA. A review of postpartum depression for the primary care physician. Southern Medical Journal. 2004; 97: 157-161.
  16. Wisner KL, Parry BL, Piontek CM. Clinical Practice. Postpartum depression. New England Journal of Medicine. 2002; 347: 194-199.
  17. Robertson E, Lyons A. Living with puerperal psychosis: a qualitative analysis. Psychology and Psychotherapy: Theory, Research and Practice. 2003; 76: 411-431.
  18. Davidson A, Robertson E. A follow-up study of postpartum illness, 1946-1978. Acta Psychiatrica Scandinavica. 1985; 71: 451-457.
  19. Terp IM, Mortensen PB. Post-partum psychoses. Clinical diagnoses and relative risk of admission after parturition. British Journal of Psychiatry. 1998; 172: 521-526.
  20. Harlow BL, Vitonis AF, Sparen P, et al. Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. Archives of General Psychiatry. 2007; 64: 42-48.
  21. O'Hara MW, Swain AM. Rates and risks of postpartum depression: a meta-analysis. International Review of Psychiatry. 1996; 8: 37-54.
  22. O'Hara MW, Swain AM. Rates and risks of postpartum depression: a meta-analysis. International Review of Psychiatry. 1996; 8: 37-54.
  23. Beck CT. A meta-analysis of predictors of postpartum depression. Nursing Research. 1996; 45: 297-303.
  24. Wilson LM, Reid AJ, Midmer DK, et al. Antenatal psychosocial risk factors associated with adverse postpartum family outcomes. Canadian Medical Association Journal. 1996; 154: 785-799.
  25. Robertson E, Grace S, Wallington T, et al. Antenatal risk factors for postpartum depression: a synthesis of recent literature. General Hospital Psychiatry. 2004; 26: 289-295.
  26. O'Hara MW, Gorman LL. Can postpartum depression be predicted? Primary Psychiatry. 2004; 11: 42-47.
  27. Nielsen Forman D, Videbech P, Hedegaard M, et al. Postpartum depression: identification of women at risk. British Journal of Obstetrics and Gynaecology. 2000; 107: 1210-1217.
  28. Hiscock H, Bayer JK, Hampton A, et al. Long-term mother and child mental health effects of a population-based infant sleep intervention: cluster-randomized, controlled trial. Pediatrics. 2008; 122: 621-627.
  29. Scottish Intercollegiate Guidelines Network. Management of perinatal mood disorders. SIGN guideline 127. March 2012. Available at http://www.sign.ac.uk/guidelines/fulltext/127/index.html (accessed on 15 July 2013).
  30. Boyce P, Hickey A. Psychosocial risk factors to major depression after childbirth. Social Psychiatry and Psychiatric Epidemiology. 2005; 40: 605-612.
  31. Wisner KL, Parry BL, Piontek CM. Clinical Practice. Postpartum depression. New England Journal of Medicine. 2002; 347: 194-199.
  32. Wood AF, Thomas SP, Droppleman PG, et al. The downward spiral of postpartum depression. MCN: American Journal of Maternal Child Nursing. 1997; 22: 308-316.
  33. Kennedy HP, Beck CT, Driscoll JW. A light in the fog: caring for women with postpartum depression. Journal of Midwifery and Women's Health. 2002; 47: 318-330.
  34. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy and screening outcomes. Evidence report/Technology assessment number 119. February 2005. Available at http://archive.ahrq.gov/clinic/tp/perideptp.htm (accessed on 15 July 2013).
  35. Clay EC, Seehusen DA. A review of postpartum depression for the primary care physician. Southern Medical Journal. 2004; 97:157-161.
  36. O'Hara MW, Swain AM. Rates and risks of postpartum depression: a meta-analysis. International Review of Psychiatry. 1996; 8: 37-54.
  37. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. British Journal of Psychiatry. 1993; 163: 27-31.
  38. Patel V, Rodrigues M, DeSouza N. Gender, poverty and postnatal depression: a study of mothers in Goa, India. American Journal of Psychiatry. 2002; 159: 43-47.
  39. Cooper PJ, Tomlinson M, Swartz L, et al. Post-partum depression and the mother-infant relationship in a South African peri-urban settlement. British Journal of Psychiatry. 1999; 175: 554-558.
  40. Cooper PJ, Murray L, Stein A. Postnatal depression. In: Seva A (editor). European Handbook of Psychiatry and Mental Health. Anthropos, Barcelona; 1991.
  41. Kumar R, Robson KM. A prospective study of emotional disorders in childbearing women. British Journal of Psychiatry. 1984; 144: 35-47.
  42. Cooper PJ, Murray L. Course and recurrence of postnatal depression: evidence for the specificity of the diagnostic concept. British Journal of Psychiatry. 1995; 166: 191-195.
  43. Ballard CG, Davis R, Cullen PC, et al. Prevalence of postnatal psychiatric morbidity in mothers and fathers. British Journal of Psychiatry. 1994; 164: 782-788.
  44. Royal College of Obstetricians and Gynaecologists. Why mothers die 1997-1999: the fifth report of the confidential enquiries into maternal deaths in the United Kingdom. RCOG Press, London, UK; 2001.
  45. Poobalan AS. Effects of treating postnatal depression on mother-infant interaction and child development: Systematic review. British Journal of Psychiatry. 2007; 191: 378-386.
  46. Martins C, Gaffan EA. Effects of early maternal depression on patterns of infant-mother attachment: a meta-analytic investigation. Journal of Child Psychology and Psychiatry, and allied disciplines. 2000; 41: 737-746.
  47. Murray L, Cooper PJ. The impact of postpartum depression on child development. International Review of Psychiatry. 1996; 8: 55-63.
  48. McLearn KT, Minkovitz CS, Strobino DM, et al. Maternal depressive symptoms at 2 to 4 months post partum and early parenting practices. Archives of Pediatric and Adolescent Medicine. 2006; 160: 279-284.
  49. Campbell SB, Cohn JF, Meyers T. Depression in first-time mothers: mother-infant interaction and depression chronicity. Developmental Psychology. 1995; 31: 349-357.
  50. Goodman JH. Postpartum depression beyond the early postpartum period. Journal of Obstetric, Gynecologic and Neonatal Nursing. 2004; 33: 410-429.
  51. Clay EC, Seehusen DA. A review of postpartum depression for the primary care physician. Southern Medical Journal. 2004; 97: 157-161.
  52. World Health Organization. International classification of diseases and related health problems. Version 10, 2nd edition. World Health Organisation, Geneva, Switzerland; 2005.
  53. National Institute for Health and Care Excellence. Depression: the treatment and management of depression in adults. October 2009. Clinical guideline 90. Available at http://www.nice.org.uk/cg090 (accessed on 15 July 2013).
  54. Wisner KL, Parry BL, Piontek CM. Clinical Practice. Postpartum depression. New England Journal of Medicine. 2002; 347: 194-199.
  55. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry. 1987; 150: 782-786.
  56. National Screening Committee. Evaluation of screening for postnatal depression against the NSC handbook criteria. September 2010. Available at http://www.screening.nhs.uk/policydb_download.php?doc=140 (accessed on 15 July 2013).
  57. National Institute for Health and Clinical Excellence. Antenatal and postnatal mental health: clinical management and service guidance. February 2007. Clinical guideline 45. Available at http://guidance.nice.org.uk/CG45 (accessed on 15 July 2013).
  58. British National Formulary. Antidepressant drugs. Section 4.3. British Medical Association and the Royal Pharmaceutical Society of Great Britain. Also available at http://bnf.org (accessed on 15 July 2013).
  59. Appleby L, Warner R, Whitton A, et al. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ. 1997; 314: 932-936.
  60. British National Formulary. Antidepressant drugs. Section 4.3. British Medical Association and the Royal Pharmaceutical Society of Great Britain. Also available at http://bnf.org (accessed on 15 July 2013).
  61. Ng RC, Hirata CK, Yeung W, et al. Pharmacologic treatment for postpartum depression: a systematic review. Pharmacotherapy. 2010; 30(9): 928-941.
  62. Joffe R, Sokolov S, Streiner D, et al. Antidepressant treatment of depression: a metaanalysis. Canadian Journal of Psychiatry (Revue Canadienne de Psychiatrie). 1996; 41: 613-616.
  63. Williams JW Jr, Mulrow CD, Chiquette E, et al. A systematic review of newer pharmacotherapies for depression in adults: evidence. Annals of Internal Medicine. 2000; 132: 743-756.
  64. Geddes JR, Freemantle N, Mason J, et al. Selective serotonin reuptake inhibitors (SSRIs) for depression (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  65. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of Affective Disorders. 2000; 58: 19-36.
  66. Massana J, Moller H-J, Burrows GD, et al. Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder. International Clinical Psychopharmacology. 1999; 14: 73-80.
  67. Behnke K, Sogaard J, Martin S, et al. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. Journal of Clinical Psychopharmacology. 2003; 23: 358-364.
  68. Wade A, Crawford GM, Angus M, et al. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. International Clinical Psychopharmacology. 2003; 18: 133-141.
  69. Gloaguen V, Cottraux J, et al. A meta-analysis of the effects of cognitive therapy in depressed patients. Journal of Affective Disorders. 1998; 49: 59-72.
  70. Fava GA, Rafanelli C, Grandi S, et al. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Archives of General Psychiatry. 1998; 55: 816-820.
  71. Wisner KL, Parry BL, Piontek CM. Clinical Practice. Postpartum depression. New England Journal of Medicine. 2002; 347: 194-199.
  72. Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. American Journal of Psychiatry. 2004; 161: 1066-1078.
  73. Misri S, Reebye P, Corral M, et al. The use of paroxetine and cognitive-behavioural therapy in postpartum depression and anxiety: a randomized controlled trial. Journal of Clinical Psychiatry. 2004; 65: 1236-1241.
  74. Trindade E, Menon D. Selective serotonin reuptake inhibitors differ from tricyclic antidepressants in adverse events. Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part 1. Evaluation of the clinical literature. Canadian Coordinating Office for Health Technology Assessment 1997. Evidence-Based Mental Health. 1998; 1: 50-51.
  75. Stahl MM, Lindquist M, Pettersson M, et al. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. European Journal of Clinical Pharmacology. 1997; 53: 163-169.
  76. Medicines and Healthcare Products Regulatory Agency. Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants. December 2004. Available at http://www.mhra.gov.uk (accessed on 15 July 2013).
  77. Rosenbaum JF, Fava M, Hoog SL, et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biological Psychiatry. 1998; 44: 77-87.
  78. U.S. Food and Drug Administration. Antidepressant use in children, adolescents and adults. August 2010. Available at http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm096273.htm (accessed on 15 July 2013).
  79. Medicines and Healthcare products Regulatory Agency. Implementation of warnings on suicidal thoughts and behaviour in antidepressants. February 2008. Available at http://www.mhra.gov.uk/NewsCentre/CON2033960 (accessed on 15 July 2013).
  80. Appleby L, Warner R, Whitton A, et al. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ. 1997; 314: 932-936.
  81. Misri S, Reebye P, Corral M, et al. The use of paroxetine and cognitive-behavioural therapy in postpartum depression and anxiety: a randomized controlled trial. Journal of Clinical Psychiatry. 2004; 65: 1236-1241.
  82. Wisner K, Hanusa BH, Perel JM, et al. Postpartum depression: a randomized trial of sertraline versus nortriptyline. Journal of Clinical Psychopharmacology. 2006; 26: 353-360.
  83. Lima MS, Moncrieff J. A comparison of drugs versus placebo for the treatment of dysthymia (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  84. Ballesteros J, Callado LF. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. Journal of Affective Disorders. 2004; 79: 137-147.
  85. Lepola UM, Loft H, Reines EH. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. International Clinical Psychopharmacology. 2003; 18: 211-217.
  86. Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. Journal of Clinical Psychiatry. 2002; 63: 331-336.
  87. Geddes JR, Freemantle N, Mason J, et al. Selective serotonin reuptake inhibitors (SSRIs) for depression (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  88. Dubini A, Bosc M, Polin V. Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning. Journal of Psychopharmacology. 1997; 11 (supplement): S17-S23.
  89. Behnke K, Sogaard J, Martin S, et al. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study. Journal of Clinical Psychopharmacology. 2003; 23: 358-364.
  90. Wade A, Crawford GM, Angus M, et al. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. International Clinical Psychopharmacology. 2003; 18: 133-141.
  91. Stewart LA, Parmar MKB. Bias in the analysis and reporting of randomized controlled trials. International Journal of Technology Assessment in Health Care. 1996; 12: 264-275.
  92. Gloaguen V, Cottraux J, et al. A meta-analysis of the effects of cognitive therapy in depressed patients. Journal of Affective Disorders. 1998; 49: 59-72.
  93. Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Comprehensive Psychiatry. 2003; 44: 234-246.
  94. Bloch M, Schmidt PJ, Danaceau M. Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry. 2000; 157: 924-930.
  95. Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996; 347: 930-933.
  96. Sherwin BB. Impact of the changing hormonal milieu on psychological functioning. In: Lobo RA (editor). Treatment of the postmenopausal woman: basic clinical aspects. Raven Press. New York, USA; 1994.
  97. Montgomery JC, Appleby L, Brincat M, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1987; 2: 297-299.
  98. Sherwin BB. Estrogen and mood in women. Endocrinologist. 2005; 15: 180-185.
  99. British National Formulary. Female sex hormones. Section 6.4.1. British Medical Association and Royal Pharmaceutical Society of Great Britain. Also available at http://bnf.org (accessed on 15 July 2013).
  100. British National Formulary. Female sex hormones. Section 6.4.1. British Medical Association and Royal Pharmaceutical Society of Great Britain. Also available at http://bnf.org (accessed on 15 July 2013).
  101. British National Formulary. Amoxicillin. Section 5.1. British Medical Association and Royal Pharmaceutical Society of Great Britain. Also available at http://bnf.org (accessed on 15 July 2013).
  102. Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996; 347: 930-933.
  103. Linde K, Mulrow CD. St John's wort for depression (Cochrane review). In: The Cochrane Library. Wiley, Chichester, UK.
  104. National Center for Complementary and Alternative Medicine. St. John's wort fact sheet. April 2013. Available at http://nccam.nih.gov/health/stjohnswort (accessed on 15 July 2013).
  105. Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St John's wort in major depression: a randomized controlled trial. Journal of the American Medical Association. 2001; 285: 1978-1986.
  106. Mannel M. Drug interactions with St John's Wort: mechanisms and clinical implications. Drug Safety. 2004; 27: 773-797.
  107. Hammerness P, Basch E, Ulbricht C, et al. St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics. Psychosomatics. 2003; 44: 271-282.
  108. Zhou S, Chan E, Pan SQ, et al. Pharmacokinetic interactions of drugs with St John's wort. Journal of Psychopharmacology. 2004; 18: 262-276.
  109. Churchill R, Hunot V, Corney R, et al. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technology Assessment. 2001; 5: 1-173.
  110. Gloaguen V, Cottraux J, et al. A meta-analysis of the effects of cognitive therapy in depressed patients. Journal of Affective Disorders. 1998; 49: 59-72.
  111. Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. American Journal of Psychiatry. 2002; 159: 1354-1360.
  112. Prendergast J, Austin MP. Early childhood nurse-delivered cognitive behavioural counselling for postnatal depression. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists. 2001; 9: 255-259.
  113. Cooper PJ, Murray L, Wilson A, et al. Controlled trial of the short and long-term effect of psychological treatment of postpartum depression. I. Impact on maternal mood. British Journal of Psychiatry. 2003; 182: 412-419.
  114. Murray L, Cooper PJ, Wilson A, et al. Controlled trial of the short and long-term effect of psychological treatment of postpartum depression: impact on the mother-child relationship and child outcome. British Journal of Psychiatry. 2003; 182: 420-427.
  115. Honey K, Bennet P, Morgan M. A brief psycho-educational group intervention for postnatal depression. British Journal of Clinical Psychology. 2002; 41: 405-409.
  116. Gloaguen V, Cottraux J, Cucherat, M et al. A meta-analysis of the effects of cognitive therapy in depressed patients. Journal of Affective Disorders. 1998; 49: 59-72.
  117. Van Schaik DJF, Van Marwijk HWJ, Van Der Windt Dawm, et al. Effectiveness of psychotherapy for depressive disorder in primary care: a systematic review. Tijdschrift voor Psychiatrie. 2002; 44: 609-619.
  118. Leichsenring F. Comparative effects of short-term psychodynamic psychotherapy and cognitive-behavioral therapy in depression: a meta-analytic approach. Clinical Psychology Review. 2001; 21: 401-419.
  119. Klein DN, Santiago NJ, Vivian D, et al. Cognitive-behavioural analysis system of psychotherapy as a maintenance treatment for chronic depression. Journal of Consulting and Clinical Psychology. 2004; 72: 681-688.
  120. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology. 2004; 72: 31-40.
  121. Markowitz JC. Interpersonal psychotherapy for chronic depression. Journal of Clinical Psychology. 2003; 59: 847-858.
  122. O'Hara MW, Stuart S, Gorman L, et al. Efficacy of interpersonal psychotherapy for postpartum depression. Archives of General Psychiatry. 2000; 57: 1039-1045.
  123. Weissman MM, Bothwell S Assessment of social adjustment by patient self-report. Archives of General Psychiatry. 1976; 33: 1111-1115.
  124. Bower P, Rowland N, Hardy R. The clinical effectiveness of counselling in primary care: a systematic review and meta-analysis. Psychological Medicine. 2003; 33: 203-215.
  125. Holden JM, Sagovsky R, Cox JL. Counselling in a general practice setting: controlled study of health visitor intervention in treatment of postnatal depression. BMJ. 1989; 298: 223-226.
  126. Cooper PJ, Murray L, Wilson A, et al. Controlled trial of the short and long-term effect of psychological treatment of postpartum depression. I. Impact on maternal mood. British Journal of Psychiatry. 2003; 182: 412-419.
  127. Dennis CL, Hodnett E. Psychosocial and psychological interventions for treating postpartum depression. In: The Cochrane Library. Wiley, Chichester, UK.
  128. Holden JM, Sagovsky R, Cox JL. Counselling in a general practice setting: controlled study of health visitor intervention in treatment of postnatal depression. BMJ. 1989; 298: 223-226.
  129. Cooper PJ, Murray L, Wilson A, et al. Controlled trial of the short and long-term effect of psychological treatment of postpartum depression. I. Impact on maternal mood. British Journal of Psychiatry. 2003; 182: 412-419.
  130. Murray L, Cooper PJ, Wilson A, et al. Controlled trial of the short and long-term effect of psychological treatment of postpartum depression: impact on the mother-child relationship and child outcome. British Journal of Psychiatry. 2003; 182: 420-427.
  131. Wickberg B, Hwang CP. Counselling of postnatal depression: a controlled study on a population based Swedish sample. Journal of Affective Disorders. 1996; 39: 209-216.
  132. Armstrong K, Edwards H The effects of exercise and social support on mothers reporting depressive symptoms: a pilot randomized controlled trial. International Journal of Mental Health Nursing. 2003; 12: 130-138.
  133. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ. 2001; 322: 763-767.
  134. Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. American Journal of Psychiatry. 2005; 162: 656-662.
  135. Parry BL, Maurer EL. Light treatment of mood disorders. Dialogues in Clinical Neuroscience. 2003; 5: 353-365.
  136. Kogan AO, Guilford PM. Side effects of short-term 10,000-lux light therapy. American Journal of Psychiatry. 1998; 155: 293-294.
  137. Corral M, Kuan A, Kostaras D. Bright Light Therapy's effect on postpartum depression. American Journal of Psychiatry. 2000; 157: 303-304.
  138. Cooper PJ, Murray L, Wilson A, et al. Controlled trial of the short and long-term effect of psychological treatment of postpartum depression. I. Impact on maternal mood. British Journal of Psychiatry. 2003; 182: 412-419.
  139. Murray L, Cooper PJ, Wilson A, et al. Controlled trial of the short and long-term effect of psychological treatment of postpartum depression: impact on the mother-child relationship and child outcome. British Journal of Psychiatry. 2003; 182: 420-427.
  140. Misri S, Kostaras X, Fox D, et al. The impact of partner support in the treatment of postnatal depression. Canadian Journal of Psychiatry. 2000; 45: 554-558.
  141. O'Hara MW, Swain AM. Rates and risks of postpartum depression: a meta-analysis. International Review of Psychiatry. 1996; 8: 37-54.
  142. Kumar R, Robson KM. A prospective study of emotional disorders in childbearing women. British Journal of Psychiatry. 1984; 144: 35-47.
  143. Ballard CG, Davis R, Cullen PC, et al. Prevalence of postnatal psychiatric morbidity in mothers and fathers. British Journal of Psychiatry. 1994; 164: 782-788.
  144. Misri S, Kostaras X, Fox D, et al. The impact of partner support in the treatment of postnatal depression. Canadian Journal of Psychiatry. 2000; 45: 554-558.
  145. Dennis C. The effect of peer support on postpartum depression: a pilot randomized controlled trial. Canadian Journal of Psychiatry. 2003; 48: 115-124.
  146. Dennis CL, Hodnett E, Kenton L, et al. Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial. BMJ. 2009; 338: a3064.
  147. Brugha T, Sharp H, Cooper S, et al. The Leister 500 Project: Social support and the development of postnatal depressive symptoms, a prospective cohort survey. Psychological Medicine. 1998; 28: 63-79.
  148. Dennis C. The effect of peer support on postpartum depression: a pilot randomized controlled trial. Canadian Journal of Psychiatry. 2003; 48: 115-124.
  149. Horowitz JA, Bell M, Trybulski J, et al. Promoting responsiveness between mothers with depressive symptoms and their infants. Journal of Nursing Scholarship. 2001; 33: 323-329.
  150. McLearn KT, Minkovitz CS, Strobino DM, et al. Maternal depressive symptoms at 2 to 4 months post partum and early parenting practices. Archives of Pediatric and Adolescent Medicine. 2006; 160: 279-284.
  151. Reck C, Weiss R, Fuchs T, et al. Psychotherapy of postnatal depression. Neurologist. 2004; 75: 1068-1073.
  152. Horowitz JA, Bell M, Trybulski J, et al. Promoting responsiveness between mothers with depressive symptoms and their infants. Journal of Nursing Scholarship. 2001; 33: 323-329.
  153. National Institute for Health and Clinical Excellence. Guidance on the use of electroconvulsive therapy (ECT). April 2011. Technological Appraisal 59. Available at http://www.nice.org.uk/TA59 (accessed on 15 July 2013).

Citations

Last Updated: July 17, 2013
This information does not replace medical advice.  If you are concerned you might have a medical problem please ask your Boots pharmacy team in your local Boots store, or see your doctor.

Popular slideshows & tools on BootsWebMD

woman looking at pregnancy test
Early pregnancy symptoms
donut on plate
The truth about sugar addiction
smiling african american woman
Best kept secrets for beautiful hair
couple watching sunset
How much do you know?
nappy being changed
How to change your baby's nappy
woman using moisturizer
Causes and home solutions
assorted spices
Pump up the flavour with spices
bag of crisps
Food cravings that wreck your diet
woman with cucumbers on eyes
How to banish dark circles and bags
probiotic shakes
Help digestion
polka dot dress on hangar
Lose weight without dieting